School of Public Health, Division of Immunology & Pathogenesis, , University ofCalifornia, Berkeley, California 94720, USA.
Infect Immun. 2011 Apr;79(4):1606-14. doi: 10.1128/IAI.01187-10. Epub 2011 Jan 31.
Inflammasomes are cytosolic multiprotein complexes that assemble in response to infectious or noxious stimuli and activate the CASPASE-1 protease. The inflammasome containing the nucleotide binding domain-leucine-rich repeat (NBD-LRR) protein NLRC4 (interleukin-converting enzyme protease-activating factor [IPAF]) responds to the cytosolic presence of bacterial proteins such as flagellin or the inner rod component of bacterial type III secretion systems (e.g., Salmonella PrgJ). In some instances, such as infection with Legionella pneumophila, the activation of the NLRC4 inflammasome requires the presence of a second NBD-LRR protein, NAIP5. NAIP5 also is required for NLRC4 activation by the minimal C-terminal flagellin peptide, which is sufficient to activate NLRC4. However, NLRC4 activation is not always dependent upon NAIP5. In this report, we define the molecular requirements for NAIP5 in the activation of the NLRC4 inflammasome. We demonstrate that the N terminus of flagellin can relieve the requirement for NAIP5 during the activation of the NLRC4 inflammasome. We also demonstrate that NLRC4 responds to the Salmonella protein PrgJ independently of NAIP5. Our results indicate that NAIP5 regulates the apparent specificity of the NLRC4 inflammasome for distinct bacterial ligands.
炎症小体是一种细胞溶质多蛋白复合物,可对感染或有害刺激作出反应,并激活半胱氨酸蛋白酶-1(CASPASE-1)蛋白酶。含有核苷酸结合域-富含亮氨酸重复序列(NBD-LRR)蛋白 NLRC4(白细胞介素转换酶蛋白酶激活因子[IPAF])的炎症小体对细菌蛋白(如鞭毛蛋白或细菌 III 型分泌系统的内杆成分)的细胞溶质存在作出反应(例如,沙门氏菌 PrgJ)。在某些情况下,例如感染嗜肺军团菌时,NLRC4 炎症小体的激活需要存在第二种 NBD-LRR 蛋白 NAIP5。NAIP5 也是 NLRC4 被最小 C 末端鞭毛蛋白激活所必需的,该蛋白足以激活 NLRC4。然而,NLRC4 的激活并不总是依赖于 NAIP5。在本报告中,我们定义了 NAIP5 在 NLRC4 炎症小体激活中的分子要求。我们证明鞭毛蛋白的 N 端可在 NLRC4 炎症小体的激活过程中减轻对 NAIP5 的需求。我们还证明 NLRC4 独立于 NAIP5 对沙门氏菌蛋白 PrgJ 作出反应。我们的结果表明,NAIP5 调节 NLRC4 炎症小体对不同细菌配体的表观特异性。
Infect Immun. 2011-1-31
Proc Natl Acad Sci U S A. 2015-2-3
Methods Mol Biol. 2023
Methods Mol Biol. 2023
Front Immunol. 2022
Molecules. 2020-10-7
Immunohorizons. 2019-9-5
J Immunol. 2010-6-18
Proc Natl Acad Sci U S A. 2010-5-25
Nat Immunol. 2010-3-28
Eur J Immunol. 2010-6
Cell. 2010-3-19
Proc Natl Acad Sci U S A. 2010-2-1
Science. 2010-1-15
Cell Host Microbe. 2009-7-23